Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Triggle

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|February 1, 1982
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridineR Fossheim, K Svarteng, A Mostad, et al.
The Journal of Biological Chemistry|February 25, 1984
Subcellular distribution of [3H]nitrendipine binding in smooth muscleA K Grover, C Y Kwan, E Luchowski, et al.
Drug Design and Discovery|July 1, 1992
QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road aheadP P Mager, R A Coburn, A J Solo, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1988
The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparationsM Hawthorn, J Ferrante, E Luchowski, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1986
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscleX Y Wei, E M Luchowski, A Rutledge, et al.
Pharmaceutical Research|November 1, 1992
Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonistsD J Triggle, Y W Kwon, P Abraham, et al.
Journal of Medicinal Chemistry|February 1, 1988
Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) seriesR Fossheim, A Joslyn, A J Solo, et al.
Biochemical Pharmacology|February 15, 1988
Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levelsP Gengo, A Skattebøl, J F Moran, et al.
Journal of Medicinal Chemistry|August 1, 1990
4-Isoxazolyl-1,4-dihydropyridines: biological, theoretical, and structural studiesN R Natale, D J Triggle, R B Palmer, et al.
European Journal of Pharmacology|August 27, 1982
Binding of [3H]nimodipine to cardiac and smooth muscle membranesR A Janis, S C Maurer, J G Sarmiento, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|February 1, 1982
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridineR Fossheim, K Svarteng, A Mostad, et al.
The Journal of Biological Chemistry|February 25, 1984
Subcellular distribution of [3H]nitrendipine binding in smooth muscleA K Grover, C Y Kwan, E Luchowski, et al.
Drug Design and Discovery|July 1, 1992
QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road aheadP P Mager, R A Coburn, A J Solo, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1988
The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparationsM Hawthorn, J Ferrante, E Luchowski, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1986
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscleX Y Wei, E M Luchowski, A Rutledge, et al.
Pharmaceutical Research|November 1, 1992
Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonistsD J Triggle, Y W Kwon, P Abraham, et al.
Journal of Medicinal Chemistry|February 1, 1988
Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) seriesR Fossheim, A Joslyn, A J Solo, et al.
Biochemical Pharmacology|February 15, 1988
Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levelsP Gengo, A Skattebøl, J F Moran, et al.
Journal of Medicinal Chemistry|August 1, 1990
4-Isoxazolyl-1,4-dihydropyridines: biological, theoretical, and structural studiesN R Natale, D J Triggle, R B Palmer, et al.
European Journal of Pharmacology|August 27, 1982
Binding of [3H]nimodipine to cardiac and smooth muscle membranesR A Janis, S C Maurer, J G Sarmiento, et al.
Pageof 15